← Leaderboards
Claire Brett
Apricity Therapeutics, Inc.
$476,567
Attributed
$784,734
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $225K · FY2017–22$250K$187.5K$125K$62.5K$0
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$448,334 · 2
FDA$336,400 · 2
By mechanism
R43$784,734 · 4
Top collaborators
- Sook Wah Yee3 shared
Most similar at Apricity Therapeutics, Inc.
Same institution · by research overlap
- Richard D Mamelok$362,738
- Huan-Chieh Chien$216,990
Others in their field
Other Emerging Leaders on “Small Molecule Inhibitor”
- John Damon Chodera · Sloan-Kettering Inst Can Research$33,081,124
- Susan Abushakra · Alzheon, Inc.$20,190,244
- Timothy M Willson · University Of Cape Town$12,760,250
- Barry Hart · Innovation Pathways, Llc$8,985,162
- Daniel Bachovchin · Sloan-Kettering Inst Can Research$8,826,435
- Kristen A Johnson · California Institute/Biomedical Research$8,530,970
Research focus
Small Molecule InhibitorPharmaceutical PreparationsMediatingSmall MoleculeCell LinePharmacotherapyInhibitor/AntagonistLibrariesPharmacologySmall Business Innovation Research GrantTissuesUptakeCellsScaffoldFluorescenceHigh Throughput ScreeningBaseLeadNovel TherapeuticsChemotherapeutic AgentAutoimmune ProcessCell MembraneDoseAutoimmune Diseases
Grant awards (4)
Intestinal Drug Transporters in Veterinary Animals$168,400
R43 · FY2022 · FD · contact PI
Drug Transporters in Farm Animals$168,000
R43 · FY2020 · FD · contact PI
A Transporter Platform Technology For Discovery of Drugs to Treat Autoimmune Disease$223,334
R43 · FY2019 · GM · contact PI
Development of a Pharmacoprotector for Platinum Toxicities$225,000
R43 · FY2017 · CA · contact PI